SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Sotera Health Company (SHC) News

Follow Sotera Health Company (SHC) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol SHC Asset equity Sector Markets 90 days 4 Last 18.225 Updated Sep 09, 2026, 07:28 PM UTC Open live news feed Open SHC chart & news
L SHC: Integrated growth, capacity expansion, and strong cash flow drive a resilient outlook The business is driving growth through integrated sterilization and lab services, robust investments in capacity and supply security, and disciplined capital allocation. Margin expansion and strong free cash flow are exp EARNINGS | Sep 09, 2026, 07:28 PM UTC L SHC: Integrated healthcare services, robust growth, and strategic investments drive future expansion The company operates three synergistic business units critical to healthcare, with strong Q2 growth in both Sterigenics and Nelson Labs. Strategic investments in capacity, regulatory compliance, and Cobalt-60 supply unde EQUITY | Sep 09, 2026, 06:42 PM UTC L Sotera Health Raises FY2026 Adj EPS Guidance from $0.93-$1.01 to $0.95-$1.01 vs $0.97 Est; Raises FY2026 Sales Guidance from $1.233B-$1.251B Sotera Health (NASDAQ: SHC ) raises FY2026 Adj EPS guidance from $0.93-$1.01 to $0.95-$1.01 vs $0.97 analyst estimate. Raises FY2026 sales outlook from $1.233 billion-$1.251 billion to $1.236 billion-$1.254 billion vs $1 EARNINGS | Aug 06, 2026, 11:03 AM UTC L SHC - Sotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 Outlook SHC - Sotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 Outlook EQUITY | Aug 06, 2026, 11:00 AM UTC M SHC: Barclays Raises PT Barclays maintains overweight rating on Sotera Health and raises price target to $19 EQUITY | Jun 24, 2026, 02:55 PM UTC